SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Cantor Fitzgerald Maintains Neutral on Arrowhead Pharmaceuticals, Raises Price Target to $50

Cantor Fitzgerald maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral and raises the price target from $24 to $50.

Benzinga · -

Cantor Fitzgerald maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral and raises the price target from $24 to $50.